Please Wait

Applying Filters...

Looking for Pharmaceutical Excipients offered by Hayashibara? Find Pullulan based excipient solutions to address drug delivery challenges on PharmaCompass.

Lactic Acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

11 API Suppliers, 4 USDMF, 1 JDMF, 6 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

107 FDF Dossiers, 16 FDA Orange Book, 56 Europe, 27 Canada, 2 Australia, 6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 3.68GM/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - 5.15GM/1000ML;N/A/1000ML;5.4GM/1000ML;2.03GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.03GM/1000ML;0.157GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;2.44GM/1000ML;0.314GM/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.157GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;20GM/1000ML;5.4GM/1000ML;3.05GM/1000ML;0.314GM/1000ML;2.21GM/1000ML;7.07GM/1000ML (5000ML), INJECTABLE;INJECTION - N/A/1000ML;N/A/1000ML;5.4GM/1000ML;2.44GM/1000ML;N/A/1000ML;3.09GM/1000ML;6.46GM/1000ML (5000ML)

RELATED EXCIPIENT COMPANIES

1 Evonik, 2 Rochem International Inc, 2 SPI Pharma, 8 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 1 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 6 BASF, 1 Beijing Mesochem Technology, 1 BioSpectra, 5 Corel Pharma Chem, 3 Finar, 6 Gangwal Chemicals, 1 Hayashibara, 2 Ideal Cures Pvt Ltd, 7 Kerry, 3 Lonza Capsugel, 1 Lubrizol Life Science Health, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qualicaps, 16 Roquette, 8 Seppic, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

23 Coating Systems & Additives, 21 Parenteral, 20 Topical, 19 Solubilizers, 16 Thickeners and Stabilizers, 16 Film Formers & Plasticizers, 12 Fillers, Diluents & Binders, 9 Taste Masking, 8 Empty Capsules, 6 Emulsifying Agents, 6 Controlled & Modified Release, 5 Co-Processed Excipients, 4 Granulation, 4 Surfactant & Foaming Agents, 4 Direct Compression, 3 API Stability Enhancers, 3 Rheology Modifiers, 2 Chewable & Orodispersible Aids, 2 Disintegrants & Superdisintegrants, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

18 NEWS #PharmaBuzz

18 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

55 Finished Drug Prices

55 Finished Drug Prices

MARKET PLACE

15 APIs, 1 FDF Dossiers, 5 EXCIPIENTS

PATENTS & EXCLUSIVITIES

5 US Patents

5 US Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

$ Xls

Filters

Lactic Acid

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Hayashibara

filter Capability Reset all filters

filter Country Reset all filters

01

Hayashibara

2024 ACI Convention

Not Confirmed